AI assistant
NUTRITIONAL GROWTH SOLUTIONS LTD — Capital/Financing Update 2025
Nov 2, 2025
65418_rns_2025-11-02_f196b1c8-0caf-4462-8aa6-bc6c230df538.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
ASX ANNOUNCEMENT | 03 November 2025
==> picture [86 x 51] intentionally omitted <==
COMMITMENTS RECEIVED FOR $2M SHARE PLACEMENT
Nutritional Growth Solutions Limited (ASX: NGS ) (" NGS " or " the Company "), a health, nutrition, and wellness company headquartered in the United States, announces that the Company has received firm commitments from sophisticated and professional investors to raise A$2,000,000 at A$0.02 per share. Under the Placement, up to 100 million new fully paid ordinary shares will be issued in the Company (“new Shares”) subject to shareholder approval at the EGM to be held in December 2025.
The proceeds from the share placement will be used towards:
-
Sales and marketing to support growth
-
Inventory build to service portfolio and distribution expansion
-
General corporate expenses and transaction costs
-
Pursuing organic and inorganic growth opportunities as they arise
Placement
The Company has agreed to issue up to 100,000,000 fully paid ordinary shares at A$0.02 per share to a number of sophisticated and professional investors to raise A$ 2,000,000, subject to shareholder approval at the EGM to be held in December 2025.
There is no related party participating in this Placement.
Taurus Capital Group Pty Ltd was the lead manager and will receive a 6% placement fee in cash. In addition, the Lead Manager will be issued 25 million options with an exercise price of A$0.025 expiring three years from the date of issue, subject to shareholder approval at the next general meeting.
-ENDS-
This announcement was authorised for release by the Board.
For further information, please contact:
Stephen Turner
Managing Director and CEO
[email protected] | [email protected]
About Nutritional Growth Solutions
Nutritional Growth Solutions is a U.S.-based health, nutrition, and wellness company. NGS develops, produces and sells clinically tested nutritional formulas for children following 20 years of medical research into pediatric nutrition. The nutritional supplements market has experienced tremendous growth in recent years, but most attention has been focused on adult users and children under the age of three. The children aged three to twelve years represent a significant market opportunity
Nutritional Growth Solutions | ASX: NGS | ARBN: 642 861 774 | www.ngsolutions.co 16885 Via Del Campo Court, Suite 218, San Diego, CA 92127
ASX ANNOUNCEMENT | 03 November 2025
==> picture [86 x 51] intentionally omitted <==
and NGS is highly differentiated from its competitors with clinically tested products and an expanding product portfolio to capture this market opportunity.
https://healthyheights.com | https://ngsolutions.co
Nutritional Growth Solutions | ASX: NGS | ARBN: 642 861 774 | www.ngsolutions.co 16885 Via Del Campo Court, Suite 218, San Diego, CA 92127